Jump to content

Search the Community

Showing results for tags 'biorisk management'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Discussions
    • Polio
    • Flu awareness
    • European Immunization Week, 23–29 April 2018
    • Migration and immunization
    • World Hepatitis Day, 28 July 2017
    • European Immunization Week, 24 - 30 April 2017
    • General discussions
    • Education on Immunization
    • Data visualization
    • About NITAGs
    • Research papers, articles, and reports
    • News and social media
    • Updates from partners and stakeholders
    • European Immunization Week (2016)
    • Job opportunities
    • Q&A about the site
    • Innsbruck Treffen (private forum)

Categories

  • European Immunization Week 2018
    • Planning resources - EIW 2018
    • Brochures - EIW 2018
    • Infographics - EIW 2018
    • Posters - EIW 2018
    • Banners and social media - EIW 2018
    • Meeting folders - EIW 2018
  • Flu Awareness - 2017
    • Flu Awareness Campaign Posters
  • European Immunization Week 2017
    • Planning resources - EIW 2017
    • Brochures - EIW 2017
    • Infographics - EIW 2017
    • Posters - EIW 2017
    • Banners and social media - EIW 2017
    • Meeting folders - EIW 2017
  • Flu Awareness - 2016
    • Flu Awareness Campaign Posters
  • EIW 2016
    • Planning resources
    • Posters
    • Meeting folders

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


About Me


Gender


Location


Country


Zip

Found 1 result

  1. Along with OPV withdrawal, an appropriate containment of eradicated polioviruses is a key objective of the Polio Eradication and Endgame Strategic Plan 2013-2018. Containment of polioviruses, as laid out in GAPIII, is taking place in 3 phases linked to global milestones in polio eradication. Current (Phase 1) activities are focused on containment of WPV2 and VDPV2, as well as on preparation for containment of vaccine polioviruses of type 2 (OPV/Sabin2). To support this process, WHO/Europe organized a poliovirus biorisk management training course on 17–20 May 2016 in Copenhagen, Denmark for representatives from all 13 Member States in the European Region intending to keep type 2 wild poliovirus (WPV2) or vaccine-derived poliovirus (VDPV2) materials for research or vaccine manufacturing purposes. More information can be found here.
×
×
  • Create New...